Adma Biologics (ADMA) Profit After Tax (QoQ) (2011 - 2025)
Adma Biologics (ADMA) Profit After Tax (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Adma Biologics | 2.04 Bn | 1.95 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.55% |
| Sep 30, 2025 | 6.46% |
| Jun 30, 2025 | 27.19% |
| Mar 31, 2025 | -75.96% |
| Dec 31, 2024 | 211.61% |
| Sep 30, 2024 | 12.00% |
| Jun 30, 2024 | 80.06% |
| Mar 31, 2024 | 200.91% |
| Dec 31, 2023 | -787.91% |
| Sep 30, 2023 | 140.26% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | 44.50% |
| Dec 31, 2022 | 17.91% |
| Sep 30, 2022 | -8.24% |
| Jun 30, 2022 | 44.96% |
| Mar 31, 2022 | -50.20% |
| Dec 31, 2021 | 6.00% |
| Sep 30, 2021 | 6.31% |
| Jun 30, 2021 | -2.86% |
| Mar 31, 2021 | 5.30% |